NCT01148940

Brief Summary

The purpose of this trial is to investigate D-Dimer levels, a surrogate marker of venous thromboembolism, in pregnant/postpartum white women as compared to pregnant/postpartum black women, and pregnant/postpartum women with sickle cell trait. The investigators will determine whether increased D-Dimer levels are reflected in a greater incidence of thrombosis in the postpartum patient, as well as the prevalence of symptomatic venous thrombosis in black patients as compared to pregnant white patients and women with sickle cell trait. The investigators will also investigate the effect of blood group on these parameters. If there is evidence that there is an increased risk of thrombosis in sickle cell trait, the investigators will plan a trial of prophylactic anticoagulation during the last trimester and the four weeks post partum for patients with sickle cell trait and compare this population to patients who do not receive prophylactic anticoagulation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2010

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 21, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 23, 2010

Completed
8 days until next milestone

Study Start

First participant enrolled

July 1, 2010

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2011

Completed
8.6 years until next milestone

Results Posted

Study results publicly available

January 2, 2020

Completed
Last Updated

December 17, 2020

Status Verified

December 1, 2020

Enrollment Period

11 months

First QC Date

June 21, 2010

Results QC Date

October 16, 2019

Last Update Submit

December 11, 2020

Conditions

Keywords

sickle cell traitthrombosisD-Dimer

Outcome Measures

Primary Outcomes (1)

  • D-Dimer Levels Than in Black Women With Hb AA and White Women With Hb AA.

    High D-Dimer levels are regarded as potentially prothrombotic markers and are often elevated in pregnancy and the postpartum. There are some data to suggest that sickle cell trait may also be prothrombotic.To investigate whether D-Dimer levels are higher in black peripartum women with SCT than in black or white pregnant/postpartum patients who have Hb AA, we will measure the D-Dimer, on a continuous scale, in the pregnant/postpartum population of each group. It is known that D-Dimer levels \>1.0 mg/ml may be predictive of increased thrombotic risk. We will compare mean D-Dimer of Black SCT women, Black AA women and White AA women to determine whether higher D-Dimer levels, which may be a measure of hypercoagulability, are higher in women with SCT.

    Date of delivery until 4-5 weeks postpartum.

Study Arms (3)

White women with Hb AA

White pregnant and postpartum women with Hb AA

Black women with Hb AA

Black pregnant and postpartum women with HbAA

Black women with Sickle Trait

Black pregnant and postpartum women with HbAS

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailswomen who are pregnant or postpartum
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Pregnant and postpartum women

You may qualify if:

  • Peripartum women (White, Black) with Hemoglobin AA or AS

You may not qualify if:

  • Hispanic ethnicity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Montefiore Medical Center (Einstein)

The Bronx, New York, 10461, United States

Location

MeSH Terms

Conditions

ThrombosisSickle Cell Trait

Condition Hierarchy (Ancestors)

Embolism and ThrombosisVascular DiseasesCardiovascular DiseasesAnemia, Sickle CellAnemia, Hemolytic, CongenitalAnemia, HemolyticAnemiaHematologic DiseasesHemic and Lymphatic DiseasesHemoglobinopathiesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Results Point of Contact

Title
Dr. Henny Billett
Organization
Albert Einstein College of Medicine

Study Officials

  • Henny H Billett, MD MSc

    Albert Einstein College of Medicine/Montefiore Medical Ctr

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Clinical Medicine and Pathology

Study Record Dates

First Submitted

June 21, 2010

First Posted

June 23, 2010

Study Start

July 1, 2010

Primary Completion

June 1, 2011

Study Completion

June 1, 2011

Last Updated

December 17, 2020

Results First Posted

January 2, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

No plans at present

Locations